A halftime analysis of 2017 drug approvals
FDA's 2017 new drug tally just topped the end-of-year total for 2016. Here are the big winners, the controversies, and the surprise approvals.
New drug approvals
FDA's 2017 new drug tally just topped the end-of-year total for 2016. Here are the big winners, the controversies, and the surprise approvals.